
Acadia Healthcare NASDAQ: ACHC reported second-quarter 2026 results that management said were in line with expectations, supported by progress at recently opened facilities, disciplined spending and strong free cash flow generation.
Acadia Healthcare Company, Inc. develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities, and outpatient behavioral health facilities to serve the behavioral health and recovery needs of the communities in the United States. United States and Puerto Rico. The company is headquartered in Franklin, Tennessee.
| Revenue (TTM) | $3.37B |
| Gross Profit (TTM) | $1.41B |
| EBITDA | $587.95M |
| Operating Margin | 10.10% |
| Return on Equity | -41.00% |
| Return on Assets | 4.20% |
| Revenue/Share (TTM) | $37.28 |
| Book Value | $21.58 |
| Price-to-Book | 1.62 |
| Price-to-Sales (TTM) | 0.89 |
| EV/Revenue | 1.686 |
| EV/EBITDA | 9.63 |
| Quarterly Earnings Growth (YoY) | -49.60% |
| Quarterly Revenue Growth (YoY) | 7.60% |
| Shares Outstanding | $91.97M |
| Float | $85.14M |
| % Insiders | 1.54% |
| % Institutions | 146.36% |
Volatility is currently contracting

Acadia Healthcare NASDAQ: ACHC reported second-quarter 2026 results that management said were in line with expectations, supported by progress at recently opened facilities, disciplined spending and strong free cash flow generation.

ACHC beats Q2 earnings and revenue estimates as admissions rise and residential treatment grow, prompting higher 2026 guidance despite profit pressure.

SAN DIEGO, July 28, 2026 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors of their rights following the court's decision to allow securities claims against Acadia Healthcare Company (NASDAQ: ACHC) to proceed. The case is continuing after the Court denied defendants' motion to dismiss the amended complaint.

SAN DIEGO--(BUSINESS WIRE)---- $ACHC #Medicine--Robbins LLP reminds investors of their rights following the court's decision to allow securities claims against Acadia Healthcare Company (NASDAQ: ACHC) to proceed.The case is continuing after the Court denied defendants' motion to dismiss the amended complaint. The ruling means the case can proceed past the motion-to-dismiss stage. It does not determine whether the allegations are true or establish liability. Investors who purchased or otherwise acquired Acadia Healt.

FRANKLIN, Tenn.--(BUSINESS WIRE)--Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that it will release its second quarter 2026 results on Tuesday, July 28, 2026, after the close of the market. Acadia will host a conference call with institutional investors and analysts on Wednesday, July 29, 2026 at 9:00 a.m. ET. A live broadcast of the conference call will be available at www.acadiahealthcare.com in the “Investors” section of the website, and the archived webcast will be availabl.

The Zacks Medical-Hospital industry is adapting as care shifts beyond inpatient settings, demand rises and earnings outlook improves. THC, UHS, ACHC and CYH stand out.

ACHC is shifting from expansion to returns, raising EBITDA guidance as mature facilities and rising demand support its turnaround strategy.

Acadia Healthcare (ACHC) reported earnings 30 days ago. What's next for the stock?

ACHC shares surge 82% YTD while it expands bed capacity, boosts cash flow and rides on rising behavioral health demand.

ACHC Q1 tops estimates with 37 cents EPS and 7.6% revenue growth, driven by higher patient days and admissions despite shorter stays and rising costs.
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on ACHC and any ticker you trade — then tracks every position and per-strategy win rate.